Review of Fungal Outbreaks and Infection Prevention in Healthcare Settings during Construction and Renovation

Clinical Infectious Diseases

Volumn 61, Issue 3, 2015, Pages 433-444

  Kanamori, Hajime ^a,b   Rutala, William A ^a,b   Sickbert Bennett, Emily E ^a,b   Weber, David J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Aspergillus; construction; fungal outbreaks; healthcare associated infections; renovation

Indexed keywords

AIR SAMPLING; ARTICLE; ASPERGILLUS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CARRIER; EPIDEMIC; FUNGUS SPORE; HEMATOLOGIC MALIGNANCY; HOSPITAL BUILDING; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LABORATORY TEST; LUNG INFECTION; MOLECULAR TYPING; MORTALITY; MYCOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; ZYGOMYCETES; CROSS INFECTION; DISEASE OUTBREAKS; ENVIRONMENTAL MONITORING; HOSPITAL DESIGN; MYCOSES;

CROSS INFECTION; DISEASE OUTBREAKS; ENVIRONMENTAL MONITORING; HOSPITAL DESIGN AND CONSTRUCTION; HUMANS; MYCOSES;

EID: 84938578094     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ297     Document Type: Article

References (83)

1. Chang CC, Athan E, Morrissey CO, Slavin MA. Preventing invasive fungal infection during hospital building works. Intern Med J 2008; 38:538-41.
2. Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect 2006; 63:246-54.
3. Stichler JF. Enhancing safety with facility design. J Nurs Adm 2007; 37:319-23.
4. Bartley J. Hospital construction: stirring up trouble. Engineered Systems, 2007. Available at: http://www.esmagazine.com/Articles/Feature-Article/ BNP-GUID-9-5-2006-A-10000000000000126814. Accessed 6 February 2015.
5. Aisner J, Schimpff SC, Bennett JE, Young VM,Wiernik PH. Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. JAMA 1976; 235:411-2.
6. Arnow PM, Andersen RL, Mainous PD, Smith EJ. Pumonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978; 118: 49-53.
7. Lentino JR, Rosenkranz MA, Michaels JA, Kurup VP, Rose HD, Rytel MW. Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners. Am J Epidemiol 1982; 116:430-7.
8. Sarubbi FA Jr, Kopf HB, Wilson MB, McGinnis MR, Rutala WA. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis 1982; 125:33-8.
9. Krasinski K, Holzman RS, Hanna B, Greco MA, Graff M, Bhogal M. Nosocomial fungal infection during hospital renovation. Infect Control 1985; 6:278-82.
10. Opal SM, Asp AA, Cannady PB Jr, Morse PL, Burton LJ, Hammer PG 2nd. Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 1986; 153:634-7.
11. Perraud M, Piens MA, Nicoloyannis N, Girard P, Sepetjan M, Garin JP. Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works. Epidemiol Infect 1987; 99:407-12.
12. Ruutu P, Valtonen V, Tiitanen L, et al. An outbreak of invasive aspergillosis in a haematologic unit. Scand J Infect Dis 1987; 19:347-51.
13. Weems JJ Jr, Davis BJ, Tablan OC, Kaufman L, Martone WJ. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infect Control 1987; 8:71-5.
14. Barnes RA, Rogers TR. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J Hosp Infect 1989; 14:89-94.
15. Hopkins CC, Weber DJ, Rubin RH. Invasive aspergillus infection: possible non-ward common source within the hospital environment. J Hosp Infect 1989; 13:19-25.
16. Klimowski LL, Rotstein C, Cummings KM. Incidence of nosocomial aspergillosis in patients with leukemia over a twenty-year period. Infect Control Hosp Epidemiol 1989; 10:299-305.
17. Weber SF, Peacock JE Jr, Do KA, Cruz JM, Powell BL, Capizzi RL. Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disorders. Infect Control Hosp Epidemiol 1990; 11:235-42.
18. Brincker H, Christensen BE, Schmidt KG, Hornstrup MK. Itraconazole treatment of pulmonary aspergillosis in leukaemia patients during a nosocomial epidemic associated with indoor building renovation. Mycoses 1991; 34:395-400.
19. Humphreys H, Johnson EM, Warnock DW, Willatts SM, Winter RJ, Speller DC. An outbreak of aspergillosis in a general ITU. J Hosp Infect 1991; 18:167-77.
20. Flynn PM, Williams BG, Hetherington SV, Williams BF, Giannini MA, Pearson TA. Aspergillus terreus during hospital renovation. Infect Control Hosp Epidemiol 1993; 14:363-5.
21. Buffington J, Reporter R, Lasker BA, et al. Investigation of an epidemic of invasive aspergillosis: utility of molecular typing with the use of random amplified polymorphic DNA probes. Pediatr Infect Dis J 1994; 13:386-93.
22. Iwen PC, Davis JC, Reed EC, Winfield BA, Hinrichs SH. Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect Control Hosp Epidemiol 1994; 15:303-6.
23. Loudon KW, Coke AP, Burnie JP, Lucas GS, Liu Yin JA. Invasive aspergillosis: clusters and sources? J Med Vet Mycol 1994; 32:217-24.
24. Alvarez M, Lopez Ponga B, Rayon C, et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol 1995; 33:3290-5.
25. Anderson K, Morris G, Kennedy H, et al. Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. Thorax 1996; 51:256-61.
26. Ansorg R, van den Boom R, von Heinegg EH, Rath PM. Association between incidence of Aspergillus antigenemia and exposure to construction works at a hospital site. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg 1996; 284:146-52.
27. Bryce EA,Walker M, Scharf S, et al. An outbreak of cutaneous aspergillosis in a tertiary-care hospital. Infect Control Hosp Epidemiol 1996; 17:170-2.
28. Loo VG, Bertrand C, Dixon C, et al. Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol 1996; 17:360-4.
29. Papouli M, Roilides E, Bibashi E, Andreou A. Primary cutaneous aspergillosis in neonates: case report and review. Clin Infect Dis 1996; 22:1102-4.
30. Sessa A, Meroni M, Battini G, et al. Nosocomial outbreak of Aspergillus fumigatus infection among patients in a renal unit? Nephrol Dial Transplant 1996; 11:1322-4.
31. Patterson JE, Zidouh A, Miniter P, Andriole VT, Patterson TF. Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol 1997; 18:104-8.
32. Tabbara KF, al Jabarti AL. Hospital construction-associated outbreak of ocular aspergillosis after cataract surgery. Ophthalmology 1998; 105: 522-6.
33. Garrett DO, Jochimsen E, Jarvis W. Invasive Aspergillus spp infections in rheumatology patients. J Rheumatol 1999; 26:146-9.
34. Rickerts V, Bohme A, Viertel A, et al. Cluster of pulmonary infections caused by Cunninghamella bertholletiae in immunocompromised patients. Clin Infect Dis 2000; 31:910-3.
35. Thio CL, Smith D, Merz WG, et al. Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol 2000; 21:18-23.
36. Burwen DR, Lasker BA, Rao N, Durry E, Padhye AA, Jarvis WR. Invasive aspergillosis outbreak on a hematology-oncology ward. Infect Control Hosp Epidemiol 2001; 22:45-8.
37. Lai KK. A cluster of invasive aspergillosis in a bone marrow transplant unit related to construction and the utility of air sampling. Am J Infect Control 2001; 29:333-7.
38. Oren I, Haddad N, Finkelstein R, Rowe JM. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol 2001; 66:257-62.
39. Raad I, Hanna H, Osting C, et al. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol 2002; 23:41-3.
40. Yonemori K, Takezako N, Nishimura K, et al. Fungal infection in neutropenic patients in a hospital during construction. Jpn J Infect Dis 2002; 55:126-7.
41. De Rosa FG, Shaz D, Campagna AC, Dellaripa PE, Khettry U, Craven DE. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case? Infect Control Hosp Epidemiol 2003; 24:477-82.
42. Panackal AA, Dahlman A, Keil KT, et al. Outbreak of invasive aspergillosis among renal transplant recipients. Transplantation 2003; 75:1050-3.
43. Florio M, Marroni M, Morosi S, Stagni G. Nosocomial Aspergillus flavus wound infections following cardiac surgery. Infez Med 2004; 12:270-3.
44. Ahmad Sarji S, Wan AbdullahW,Wastie M. Imaging features of fungal infection in immuno-suppressed patients in a local ward outbreak. Biomed Imaging Interv J 2006; 2:e21.
45. Berthelot P, Loulergue P, Raberin H, et al. Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards. Clin Microbiol Infect 2006; 12:738-44.
46. Kidd F, Buttner C, Kressel AB. Construction: a model program for infection control compliance. Am J Infect Control 2007; 35:347-50.
47. Nataloni S, Gabbanelli V, Rossi R, Donati A, Pantanetti S, Pelaia P. Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in intensive care unit. Minerva Anestesiol 2007; 73:371-5.
48. Raviv Y, Kramer MR, Amital A, Rubinovitch B, Bishara J, Shitrit D. Outbreak of aspergillosis infections among lung transplant recipients. Transpl Int 2007; 20:135-40.
49. Chang CC, Cheng AC, Devitt B, et al. Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works. J Hosp Infect 2008; 69:33-8.
50. Pini G, Faggi E, Donato R, Sacco C, Fanci R. Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation. Mycoses 2008; 51:117-22.
51. Chabrol A, Cuzin L, Huguet F, et al. Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia. Haematologica 2010; 95:996-1003.
52. Garnaud C, Brenier-Pinchart MP, Thiebaut-Bertrand A, et al. Sevenyear surveillance of nosocomial invasive aspergillosis in a French university hospital. J Infect 2012; 65:559-67.
53. Pokala HR, Leonard D, Cox J, et al. Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia. Pediatr Blood Cancer 2014; 61:276-80.
54. Rammaert B, Lanternier F, Zahar JR, et al. Healthcare-associated mucormycosis. Clin Infect Dis 2012; 54(suppl 1):S44-54.
55. Haiduven D. Nosocomial aspergillosis and building construction. Med Mycol 2009; 47(suppl 1):S210-6.
56. Richardson M. The ecology of the Zygomycetes and its impact on environmental exposure. Clin Microbiol Infect 2009; 15(suppl 5):2-9.
57. Jackson L, Klotz SA, Normand RE. A pseudoepidemic of Sporothrix cyanescens pneumonia occurring during renovation of a bronchoscopy suite. J Med Vet Mycol 1990; 28:455-9.
58. Hruszkewycz V, Ruben B, Hypes CM, Bostic GD, Staszkiewicz J, Band JD. A cluster of pseudofungemia associated with hospital renovation adjacent to the microbiology laboratory. Infect Control Hosp Epidemiol 1992; 13:147-50.
59. Laurel VL, Meier PA, Astorga A, Dolan D, Brockett R, Rinaldi MG. Pseudoepidemic of Aspergillus Niger infections traced to specimen contamination in the microbiology laboratory. J Clin Microbiol 1999; 37:1612-6.
60. Freeman J, Rogers K, Roberts S. Pseudo-outbreak of Aspergillus keratitis following construction in an ophthalmology ward. J Hosp Infect 2007; 67:104-5.
61. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32:358-66.
62. Vandewoude KH, Blot SI, Benoit D, Colardyn F, Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect 2004; 56:269-76.
63. Warris A, Klaassen CH, Meis JF, et al. Molecular epidemiology of Aspergillus fumigatus isolates recovered fromwater, air, and patients shows two clusters of genetically distinct strains. J Clin Microbiol 2003; 41: 4101-6.
64. Anaissie EJ, Stratton SL, Dignani MC, et al. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 2002; 34:780-9.
65. Morrison J, Yang C, Lin KT, Haugland RA, Neely AN, Vesper SJ. Monitoring Aspergillus species by quantitative PCR during construction of a multi-storey hospital building. J Hosp Infect 2004; 57:85-7.
66. Goebes MD, Baron EJ, Mathews KL, Hildemann LM. Effect of building construction on Aspergillus concentrations in a hospital. Infect Control Hosp Epidemiol 2008; 29:462-4.
67. Hovi L, Saxen H, Saarinen-Pihkala UM, Vettenranta K, Meri T, Richardson M. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr Blood Cancer 2007; 48:28-34.
68. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5:609-22.
69. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42:1417-27.
70. Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1?3)-?-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009; 49:1650-9.
71. Harrison E, Stalhberger T, Whelan R, et al. Aspergillus DNA contamination in blood collection tubes. Diagn Microbiol Infect Dis 2010; 67:392-4.
72. Koo S, Thomas HR, Daniels SD, et al. A breath fungal secondary metabolite signature to diagnose invasive aspergillosis. Clin Infect Dis 2014; 59:1733-40.
73. Hoenigl M, Prattes J, Spiess B, et al. Performance of galactomannan, beta-D-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2014; 52:2039-45.
74. Hansen D, Blahout B, Benner D, Popp W. Environmental sampling of particulate matter and fungal spores during demolition of a building on a hospital area. J Hosp Infect 2008; 70:259-64.
75. Hajjeh RA, Warnock DW. Counterpoint: invasive aspergillosis and the environment-rethinking our approach to prevention. Clin Infect Dis 2001; 33:1549-52.
76. Hagiwara D, Takahashi H, Watanabe A, et al. Whole-genome comparison of Aspergillus fumigatus strains serially isolated from patients with aspergillosis. J Clin Microbiol 2014; 52:4202-9.
77. Centers for Disease Control and Prevention. Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52(No. RR-10): 1-48.
78. Sehulster LM, Chinn RYW, Arduino MJ, et al. Guidelines for environmental infection control in health-care facilities. Recommendations from CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Chicago, IL: American Society for Healthcare Engineering/American Hospital Association, 2004.
79. Facility Guidelines Institute. Guidelines for design and construction of hospitals and outpatient facilities. Chicago, IL: American Society for Healthcare Engineering of the American Hospital Association, 2014.
80. French Society for MedicalMycology and the French Society for Hospital Hygiene. Risk of fungal infections, and construction work in hospitals, 2011. Available at: http://www.sf2h.net/SF2H-english/SF2H-SFMM- fungal-infections-guidelines-2011.pdf. Accessed 2 March 2015.
81. Berger J,Willinger B, Diab-Elschahawi M, et al. Effectiveness of preventive measures for hemato-oncologic patients undergoing stem cell transplantation during a period of hospital construction. Am J Infect Control 2011; 39:746-51.
82. Eckmanns T, Ruden H, Gastmeier P. The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review. J Infect Dis 2006; 193:1408-18.
83. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52:427-31.